Zinc-finger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients

被引:31
作者
Dong, XY [1 ]
Yang, XA [1 ]
Wang, YD [1 ]
Chen, WF [1 ]
机构
[1] Peking Univ, Dept Immunol, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100083, Peoples R China
关键词
zinc-finger protein; transcription factor; cancer-testis antigen; serum antibody; tumorigenesis;
D O I
10.1038/sj.bjc.6602138
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ZNF165 is a zinc-finger protein gene that was identified from human adult testis. Analysis of the origins of publicly available expressed sequence tags as presented in Unigene and SAGE databases revealed that ZNF165 mRNA was expressed in tumours of different tissues. RT-PCR, real-time PCR and Northern blotting analysis confirmed that ZNF165 mRNA was expressed in the hepatocellular carcinoma, gastric cancer, colon cancer and non-small-cell lung carcinoma. The nucleotide sequence of ZNF165 expressed in tumours is identical to that expressed in the testis. Humoral responses of hepatocellular carcinoma (HCC) patients against ZNF165 protein were determined by Western blotting using the recombinant ZNF165 protein. Antibodies against ZNF165 protein were detected in approximately 5% (four of 82) of the sera from HCC patients. These results suggest that ZNF165, a member of the ZNF family, is a novel CT antigen capable of eliciting humoral immune response and be involved in tumour biology.
引用
收藏
页码:1566 / 1570
页数:5
相关论文
共 21 条
[1]   THE MOLECULAR-GENETICS OF CANCER [J].
BISHOP, JM .
SCIENCE, 1987, 235 (4786) :305-311
[2]  
Compagni A, 2000, BRIT J CANCER, V83, P1
[3]   TRANSCRIPTION AND CANCER [J].
COX, PM ;
GODING, CR .
BRITISH JOURNAL OF CANCER, 1991, 63 (05) :651-662
[4]   Characterization of the physical interaction of Gli proteins with SUFU proteins [J].
Dunaeva, M ;
Michelson, P ;
Kogerman, P ;
Toftgard, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) :5116-5122
[5]  
GIORGIO P, 2002, CANC IMMUNITY, V2, P6
[6]   Immune responses to tumour antigens:: implications for antigen specific immunotherapy of cancer [J].
Jäger, D ;
Jäger, E ;
Knuth, A .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (09) :669-674
[7]  
Kennedy RC, 2003, CANCER RES, V63, P1040
[8]   Cancer/testis antigens: Structural and immunobiological properties [J].
Kirkin, AF ;
Dzhandzhugazyan, KN ;
Zeuthen, J .
CANCER INVESTIGATION, 2002, 20 (02) :222-236
[9]   The novel BORIS+CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer [J].
Klenova, EA ;
Morse, HC ;
Ohlsson, RF ;
Lobanenkov, VV .
SEMINARS IN CANCER BIOLOGY, 2002, 12 (05) :399-414
[10]   Cancer immunotherapy in clinical oncology [J].
Knuth, A ;
Jäger, D ;
Jäger, E .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (Suppl 1) :S46-S51